Close Menu

NEW YORK – 10x Genomics today priced its initial public offering of 10 million shares of its common stock at $39 per share.

The Pleasanton, California-based single-cell sequencing firm said that underwriters will have the right to purchase up to an additional 1.5 million shares of its common stock at the IPO price.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

CBS This Morning highlights recent Medicare fraud involving offers of genetic testing.

Researchers find that many cancer drugs in development don't work quite how their developers thought they did, as Discover's D-brief blog reports.

Mariya Gabriel, a Bulgarian politician, is to be the next European Union research commissioner, according to Science.

In Science this week: a survey indicates that US adults are more likely to support the agricultural use of gene drives if they target non-native species and if they are limited, and more.